Clinical Pathways: Recommendations for Putting Patients at the Center of Value-Based Care

Abstract

Two major trends that have been affecting the provision of oncology care in the United States are a shift from volume-based to value-based care and a push toward patient-centered healthcare. However, these two trends are not always completely aligned with each other. Value-based payment models, including clinical pathways, are one strategy being implemented by oncology stakeholders to help encourage the uptake of value-based oncology care. If structured with the patient in mind, they can improve quality of care for patients with cancer, decrease inappropriate care while enabling appropriate personalization of care, and constrain rising prices by demanding a stronger link between cost and value. If not structured appropriately, they can limit patient choice, impede access to innovative treatments, and encourage one-size-fits-all oncology care. .

RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks

“…PCP represent health management tools that indicate the sequence of the procedures that need to be carried out on the basis of the current scientific knowledge and on the available organizational, professional and technological resources [ 8 – 13 ]. The approach used to assess and analyse PCP is related to the general concept of process management that considers the path of the patient from an organisational point of view.…”

“…In this scenario, it appears clear that PCP can have an evident role in accomplishing ERNs’ mission to facilitate an equitable access to timely diagnosis and delivery of high quality, accessible and cost-effective healthcare for all patients with RCD. PCP are in fact considered crucial in providing patient-centered care and in the promotion of an efficient use of resources [ 13 ].…”

Physiotherapists' experiences of managing persons with suspected cauda equina syndrome: Overcoming the challenges

“…Participants described how a clinical pathway simplified the otherwise ‘intimidating’ task of managing persons with suspected CES. Pathways are advocated across healthcare literature for their role in facilitating provision of the safe, cost‐effective and standardised care which may benefit persons receiving care and organisations (Abrahams et al, 2017; Buchert & Butler, 2016; O'Leary et al, 2014). There is also some evidence for staff satisfaction relating to clinical pathways (Schuld et al, 2011).…”

RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks

“…PCP represent health management tools that indicate the sequence of the procedures that need to be carried out on the basis of the current scienti c knowledge and on the available organizational, professional and technological resources (8)(9)(10)(11)(12)(13). The approach used to assess and analyse PCP is related to the general concept of process management that considers the path of the patient from an organisational point of view.…”

“…In this scenario, it appears clear that PCP can have an evident role in accomplishing ERNs' mission to facilitate an equitable access to timely diagnosis and delivery of high quality, accessible and cost-effective healthcare for all patients with RCD. PCP are in fact considered crucial in providing patient-centered care and in the promotion of an e cient use of resources (13).…”